David has more than 25 years of experience in the pharmaceutical industry with a focus on the development of formulation and drug delivery technologies to support pharmaceutical product development. David is currently the VP of Research at Insmed, Inc, where he is part of a team developing novel, targeted therapies to help serve the critical unmet needs of patients battling serious rare diseases. Prior to joining Insmed, David worked at Aradigm (1996 to 2018) and Genentech, Inc. (1988 to 1996). David holds a chemical engineering degree from MIT (SB) and UC Davis (MS) and a pharmacy degree from the University of Sydney (PhD). David served as chair of IPAC-RS (2006-2008), chair of the ISAM Regulatory Affairs Working Group (2009-2010, 2017-2018, 2019-2020) and ISAM Board Member (2011-2015). He is on the editorial board of the Journal of Aerosol Medicine and Pulmonary Drug Delivery (2008-present), the Inhalation Magazine (2008-present) and Pharmaceutical Patent Analyst (2012-present).